Identified: human monoclonal antibodies effective against bird flu and seasonal flu viruses

Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.

Source

Bird Flu Vaccination

A European consortium has developed a vaccination against the avian H7N1 Influenza. The new vaccination achieved good results in clinical trials and has a high chance of being approved for clinical use. This new vaccine can save human and animal lives and prevent an outbreak of "pandemic" Influenza.

Source